Published in Cancer Med on December 21, 2015
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06
Cancer screening in elderly patients: a framework for individualized decision making. JAMA (2001) 9.79
KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant (2009) 6.43
Cancer after kidney transplantation in the United States. Am J Transplant (2004) 5.08
Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant (2004) 4.04
Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial. Transplantation (2011) 1.66
Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant. Nephrol Dial Transplant (2012) 1.48
Positron Emission Tomography (PET) in Oncology. Cancers (Basel) (2014) 1.41
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ (2010) 1.18
Cancer risk after renal transplantation in Japan. Int J Cancer (1997) 1.13
Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009. Eur J Cancer (2012) 1.12
Risk factors for malignancy in Japanese renal transplant recipients. Cancer (2007) 1.10
Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance. Nephrol Dial Transplant (2007) 0.99
Minimizing the risk of posttransplant malignancy. Transplantation (2009) 0.97
Managing cancer risk and decision making after kidney transplantation. Am J Transplant (2008) 0.91
De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr. Clin Transplant (2012) 0.87
Malignancies after kidney transplantation: Hong Kong renal registry. Am J Transplant (2012) 0.84
De novo breast cancer in renal transplant recipients. Transplant Proc (2002) 0.84
Posttransplant lymphoproliferative disease after pediatric solid organ transplantation. Clin Dev Immunol (2013) 0.83
Clinical significance of gastric cancer surveillance in renal transplant recipients. World J Surg (2012) 0.77
Two Japanese cases of birt-hogg-dubé syndrome with pulmonary cysts, fibrofolliculomas, and renal cell carcinomas. Case Rep Dermatol (2014) 0.90
Carbamylated erythropoietin protects the kidneys from ischemia-reperfusion injury without stimulating erythropoiesis. Biochem Biophys Res Commun (2006) 0.85
Decreased fucosylated PSA as a urinary marker for high Gleason score prostate cancer. Oncotarget (2016) 0.80
DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells. Oncotarget (2014) 0.79
Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer. Oncotarget (2016) 0.77
NFATc1 Expression as a Prognosticator in Urothelial Carcinoma of the Upper Urinary Tract. Transl Oncol (2017) 0.75
Novel hydrogen-producing Si-based agent reduces oxidative stress, improves sperm motility and in vitro fertilization rate in varicocele. Andrology (2020) 0.75
Peripheral blood monocyte count reflecting tumor-infiltrating macrophages is a predictive factor of adverse pathology in radical prostatectomy specimens. Prostate (2017) 0.75
Urothelial ATP signaling: what is its role in bladder sensation? Neurourol Urodyn (2016) 0.75